journal article

O-39 HER2 positive early breast cancers: What proportion are receiving adjuvant Trastuzumab therapy? A multicentre audit

Authors
Publication date
1 September 2010
Publisher
Published by Elsevier Ltd.
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Crossref

      redirect
      oaiinfo:doi/10.1016%2Fj.ejcsup.20...
      Last time updated on 05/06/2019

      Elsevier - Publisher Connector

      redirect
      oaidoi:10.1016/j.ejcsup.2010.06.0...
      Last time updated on 05/05/2017

      Elsevier - Publisher Connector

      redirect
      oaidoi:10.1016/j.ejcsup.2010.06.0...
      Last time updated on 04/06/2019